19 Indeed, a meta analysis comparing the use of ACE inhibitors or angiotensin receptor blockers in patients with cancer 4964 patients, 11 trials; urothelial, breast, hepatocellular, renal, pancreatic, prostate, non small cell lung, colorectal cancers showed that the use of ACE inhibitors or angiotensin receptor blockers resulted in a significant improvement